Novolog 100 unit/ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY5KJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,255
Award facts
- Contract value 100% obligated
- $1,255.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of NovoLog 100 Unit/mL vial 10mL insulin medication with a ceiling value of $1,255.40. This is a firm fixed price delivery order with an ultimate completion date of November 28, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for insulin aligns with AmerisourceBergen's established role as a pharmaceutical prime vendor supporting military and veteran healthcare systems through competitively awarded contracts with the DLA.
Quick answers
Who was awarded contract SPE2DR26FY5KJ?
SPE2DR26FY5KJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FY5KJ worth?
The government has obligated $1,255 on SPE2DR26FY5KJ.
Is contract SPE2DR26FY5KJ an order under another contract?
Yes. SPE2DR26FY5KJ is a delivery order under SPE2DR25D1006, an indefinite delivery contract.
Was contract SPE2DR26FY5KJ competed?
The extent of competition for SPE2DR26FY5KJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award